Afuco™ Anti-IFNG ADCC Therapeutic Antibody (Fontolizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IFNG. Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-TAB-041 |
| Pricing | Inquiry |
| Host | Human |
| Target | IFNG |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | IP, IF, FuncS, FC, Neut, ELISA |
| Storage | Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |